A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

• Status: Terminated
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The study was to determine the safe and effective dose of TBC3711 in patients with uncontrolled high blood pressure while already taking blood pressure medications.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide

Criteria

Inclusion Criteria:

• Diagnosis of resistant hypertension.

• A stable anti-hypertensive drug regimen for at least 30 days.

Exclusion Criteria:

• Sustained blood pressure greater than or equal to 180/120 mmHg.

• Required use of thigh cuff for blood pressure readings.

• Uncontrolled diabetes mellitus.